← Back to Search

Procedure

Botox for Spinal Cord Injury

Seattle, WA
Phase < 1
Waitlist Available
Led By Claire C Yang, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female 18-65 years of age at time of SCI
Be older than 18 years old
Must not have
Acute (as part of concurrent hospitalization) or history of bladder surgery (urethral or prostate surgery acceptable) or injury
Inability to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up each participant will be evaluated for a period of up to 12 months after the time of enrollment.

Summary

This trial aims to study how starting early treatment with bladder chemodenervation can help preserve bladder function in individuals with a new spinal cord injury (SCI). The researchers want to track the changes that happen in

See full description
Who is the study for?
This trial is for individuals with a new spinal cord injury (SCI) who may experience delayed wound healing. The study aims to see if early treatment can help preserve bladder function. Specific eligibility details are not provided, but typically participants must meet certain health conditions and cannot have factors that would exclude them from safely participating.Check my eligibility
What is being tested?
The study is testing the effectiveness of an early intervention called bladder chemodenervation using Botox compared to a sham procedure with saline solution. It seeks to understand how this treatment might prevent negative changes in bladder function following SCI.See study design
What are the potential side effects?
While specific side effects are not listed, Botox injections can generally cause pain at the injection site, urinary tract infections, difficulty urinating, and potentially systemic effects like muscle weakness or trouble breathing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old and have a spinal cord injury.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had bladder, urethral, or prostate surgery or an injury.
 show original
Select...
I am unable to understand or sign the consent form.
 show original
Select...
I don't have any health issues that would make bladder tests or treatments unsafe.
 show original
Select...
My heart condition is unstable.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~each participant will be evaluated for a period of up to 12 months after the time of enrollment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and each participant will be evaluated for a period of up to 12 months after the time of enrollment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of Enrollment goals
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Secondary study objectives
Variance of measurements for functional data
Variance of measurements for histological data

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Bladder Chemodenervation (Botox) Injection ProcedureActive Control1 Intervention
BoNT-A (Botox) 200 U, will be injected into the detrusor (bladder wall muscle).
Group II: Bladder Sham (saline) Injection ProcedurePlacebo Group1 Intervention
Saline will be injected into the detrusor (bladder wall muscle).

Find a Location

Closest Location:Harborview Medical Center· Seattle, WA

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,853 Previous Clinical Trials
2,021,851 Total Patients Enrolled
Claire C Yang, MDPrincipal InvestigatorUniversity of Washington
~7 spots leftby Apr 2028